Compugen Ltd. (TLV:CGEN)
Israel · Delayed Price · Currency is ILS · Price in ILA 489.00
-14.20 (-2.82%)
Aug 14, 2025, 5:24 PM IDT
Compugen Employees
Compugen had 74 employees as of December 31, 2024. The number of employees increased by 6 or 8.82% compared to the previous year.
Employees
74
Change (1Y)
6
Growth (1Y)
8.82%
Revenue / Employee
1.01M ILS
Profits / Employee
-881.66K ILS
Market Cap
468.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 74 | 6 | 8.82% |
| Dec 31, 2023 | 68 | -1 | -1.45% |
| Dec 31, 2022 | 69 | -4 | -5.48% |
| Dec 31, 2021 | 73 | 5 | 7.35% |
| Dec 31, 2020 | 68 | 7 | 11.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 35,686 |
| Danel (Adir Yeoshua) | 4,290 |
| Kamada | 420 |
| Bait Bakfar | 227 |
| SofWave Medical | 126 |
| BrainsWay | 120 |
| Novolog (Pharm-Up 1966) | 936 |
| Ilex Medical | 178 |
Compugen News
- 6 days ago - Compugen: Potential Best-In-Class Anti-PVRIG COM701 Shifts To Targeting PSOC Patients - Seeking Alpha
- 7 days ago - Compugen signals leadership transition and advances COM701 ovarian cancer trial with interim data targeted for 2026 - Seeking Alpha
- 7 days ago - Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Compugen misses Q2 estimates - Seeking Alpha
- 8 days ago - Compugen Reports Second Quarter 2025 Results - PRNewsWire
- 9 days ago - Compugen Q2 2025 Earnings Preview - Seeking Alpha
- 17 days ago - Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resistant Ovarian Cancer at ESMO 2025 - PRNewsWire
- 22 days ago - Compugen to Release Second Quarter 2025 Results on Wednesday, August 6, 2025 - PRNewsWire